Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
Our understanding of the molecular processes underlying Alzheimer’s disease (AD) is still limited, hindering the development of effective treatments, and highlighting the need for human-specific models. Advances in identifying components of the amyloid cascade are progressing, including the role of...
Main Authors: | Jacqueline P. Robbins, Leo Perfect, Elena M. Ribe, Marcello Maresca, Adrià Dangla-Valls, Evangeline M. Foster, Richard Killick, Paulina Nowosiad, Matthew J. Reid, Lucia Dutan Polit, Alejo J. Nevado, Daniel Ebner, Mohammad Bohlooly-Y, Noel Buckley, Menelas N. Pangalos, Jack Price, Simon Lovestone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2018.00504/full |
Similar Items
-
Clusterin is required for β-Amyloid toxicity in human iPSC-derived neurons
by: Robbins, J, et al.
Published: (2018) -
Immunohistochemical expression of clusterin in colorectal carcinoma
by: Jalal Ali Jalal, et al.
Published: (2021-08-01) -
Clinical significance of clusterin expression in pancreatic adenocarcinoma
by: Jin Junshuo, et al.
Published: (2012-07-01) -
Downregulation of Clusterin Expression in Human Testicular Seminoma
by: Bianjiang Liu, et al.
Published: (2013-11-01) -
Glycosylated clusterin species facilitate Aβ toxicity in human neurons
by: Evangeline M. Foster, et al.
Published: (2022-11-01)